Differences
This shows you the differences between two versions of the page.
| Next revision | Previous revision | ||
| content:alpha-1_antitrypsin_serum [2020/02/16 19:08] – created icna | content:alpha-1_antitrypsin_serum [2022/04/30 11:54] (current) – changed pubmed syntax administrator@icnapedia.org | ||
|---|---|---|---|
| Line 1: | Line 1: | ||
| - | ====== Alpha-1 antitrypsin ====== | + | ====== Alpha-1 antitrypsin, serum ====== |
| Late neonatal intracranial haemorrhage | Late neonatal intracranial haemorrhage | ||
| ==== Notes ==== | ==== Notes ==== | ||
| - | * Alpha-1-antitrypsin (AAT) deficiency is a rare genetic disorder characterized by hepatitis in neonates, childhood and adulthood (protease inhibitor (PI)*ZZ) and emphysema with or without hepatitis (PI*ZZ)/ | + | * Alpha-1-antitrypsin (AAT) deficiency is a rare genetic disorder characterized by hepatitis in neonates, childhood and adulthood (protease inhibitor (PI)*ZZ) and emphysema with or without hepatitis (PI*ZZ)/ |
| * AAT deficiency is a rare genetic disorder that can lead to a serious bleeding disorder in the neonatal period if not recognised on time | * AAT deficiency is a rare genetic disorder that can lead to a serious bleeding disorder in the neonatal period if not recognised on time | ||
| ==== References ==== | ==== References ==== | ||
| ~~REFNOTES~~ | ~~REFNOTES~~ | ||
| + | {{tag> | ||